Varaico: Literature-Extracted Genetic Variants

Gene:CYP21A2
Variant:p.I172N
Back to variants list

CYP21A2

NM_000500.9:p.I172N

Associated Papers

A Decade-Long Diagnostic Challenge: A Case of Nonclassical 21-Hydroxylase Deficiency Mistaken for Polycystic Ovary Syndrome.

Kondo E et al.

The Journal of Obstetrics and Gynaecology Research, 2026

Assisted Reproduction Technology Treatment Outcomes in Female Carriers of 21-Hydroxylase Deficiency.

Arcaz AC et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Predicting Residual 21-Hydroxylase Enzymatic Activity in Pediatric and Adult Congenital Adrenal Hyperplasia Patients: Towards Individualized Therapy.

Bindellini D et al.

Cpt: Pharmacometrics & Systems Pharmacology, 2025

Newborn screening for congenital adrenal hyperplasia due to 21 hydroxylase deficiency: the Italian experience 2006-2019.

Baronio F et al.

Journal of Endocrinological Investigation, 2025

Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-Hydroxylase Deficiency in 457 Individuals.

Lao Q et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Longitudinal Characterization and Sonographic Staging of Testicular Adrenal Rest Tumors.

Vaid S et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Genotype-Phenotype Correlation in Children With Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Using Next Generation Sequencing.

Atas N et al.

Molecular Genetics & Genomic Medicine, 2025

PGT-M as A Family Planning Tool for A Couple in Which The Woman Carries A Novel NCAH Variant and A CYP21A2 Variant also Present in Her Husband: A Case Report.

Cavagnoli M et al.

International Journal of Fertility & Sterility, 2025

Unique Case Report: A Rare Association of 21-Hydroxylase Deficiency with Triple X Karyotype.

de Sousa Azulay RS et al.

Genes, 2025

Can Incorporating Molecular Testing Improve the Accuracy of Newborn Screening for Congenital Adrenal Hyperplasia?

Sarafoglou K et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Identification of a Homozygous Variant in the CYP21A2 Gene by Next-Generation Sequencing Analysis of Circulating Cell-Free Fetal DNA.

Petrillo N et al.

Genes, 2025

Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Engberg H et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Genetics and Pathophysiology of Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

Yang M et al.

The Journal of Clinical Endocrinology and Metabolism, 2025

Assessing cortisol levels in non-classical congenital adrenal hyperplasia: focus on the V281L variant.

Bilici ME et al.

Therapeutic Advances in Endocrinology and Metabolism, 2025

Genotype-Phenotype Correlation and Feminizing Surgery in Danish Children with Congenital Adrenal Hyperplasia.

Lind-Holst M et al.

Hormone Research in Paediatrics, 2024

Novel rapid molecular diagnosis methods for comprehensive genetic analysis of 21-hydroxylase deficiency.

Xia Y et al.

Orphanet Journal of Rare Diseases, 2024

Landscape of congenital adrenal hyperplasia cases in adult endocrinology clinics of Türkiye-a nation-wide multicentre study.

Ertorer ME et al.

Endocrine, 2024

Non Typical Type 1 Diabetes Mellitus Onset in a Child With Salt-Wasting Congenital Adrenal Hyperplasia.

Rodofile F et al.

Jcem Case Reports, 2024

High carrier frequency of CYP21A2 gene mutations in Southern India - underscoring the need for genetic testing in Congenital Adrenal Hyperplasia.

Ravichandran L et al.

Endocrine, 2024

APF2: an improved ensemble method for pharmacogenomic variant effect prediction.

Zhou Y et al.

The Pharmacogenomics Journal, 2024

38802404 (PubMed )
Supplement: 41397_2024_338_MOESM2_ESM.xlsx › Sheet1

Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center.

Neocleous V et al.

Orphanet Journal of Rare Diseases, 2024

Genotype-Specific Cortisol Reserve in a Cohort of Subjects With Nonclassic Congenital Adrenal Hyperplasia (NCCAH).

Koren I et al.

The Journal of Clinical Endocrinology and Metabolism, 2024

Pregnancy management of IVF-ET pregnancies in a patient with classical 21-hydroxylase deficiency: A case report and review of the literature.

Yu J et al.

European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2024

Prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency through molecular genetic analysis of the CYP21A2 gene.

Yoon JH et al.

Annals of Pediatric Endocrinology & Metabolism, 2024

Maternal uniparental disomy for chromosome 6 in 2 prenatal cases with IUGR: case report and literature review.

Jiang Y et al.

Molecular Cytogenetics, 2024

Growth and Treatment in Congenital Adrenal Hyperplasia: An Observational Study from Diagnosis to Final Height.

Gidlöf S et al.

Hormone Research in Paediatrics, 2024

Bone mineral density determinants in adolescents and young adults with congenital adrenal hyperplasia.

Navardauskaite R et al.

Frontiers in Pediatrics, 2024

Differences in Hyperandrogenism Related to Early Detection of Non-Classical Congenital Adrenal Hyperplasia on Second Newborn Screen.

McCann-Crosby B et al.

International Journal of Neonatal Screening, 2023

Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management.

Sarafoglou K et al.

The Journal of Clinical Endocrinology and Metabolism, 2023

Long-read sequencing: An effective method for genetic analysis of CYP21A2 variation in congenital adrenal hyperplasia.

Li H et al.

Clinica Chimica Acta; International Journal of Clinical Chemistry, 2023

Cost-effective genotyping for classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) in resource-poor settings: multiplex ligation probe amplification (MLPA) with/without sequential next-generation sequencing (NGS).

Monteiro A et al.

Hormones (athens, Greece), 2023

Genotype-phenotype association in congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children.

Ermakhanova T et al.

Clinical Endocrinology, 2023

Mutation distributions among patients with congenital adrenal hyperplasia from five regions of Brazil: a systematic review.

Hosomi SS et al.

Archives of Endocrinology and Metabolism, 2023

Characteristics of Congenital Adrenal Hyperplasia Diagnosed in Adulthood: A Literature Review and Case Series.

Hubska J et al.

Journal of Clinical Medicine, 2023

Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Saho R et al.

Frontiers in Endocrinology, 2023

Lessons Learned from 17 Years of Multidisciplinary Care for Differences of Sex Development Patients at a Single Indonesian Center.

Faradz SMH et al.

Sexual Development : Genetics, Molecular Biology, Evolution, Endocrinology, Embryology, and Pathology of Sex Determination and Differentiation, 2023

Rare combination of simple virilizing form of 21-hydroxylase deficiency, Graves' disease and 47, XXX in a woman: A case report.

Liang D et al.

Medicine, 2022

Syrian females with congenital adrenal hyperplasia: a case series.

Dehneh N et al.

Journal of Medical Case Reports, 2022

Molecular analysis and genotype-phenotype correlations in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency from southern Poland - experience of a clinical center.

Kurzyńska A et al.

Hormones (athens, Greece), 2022

CAH-X Syndrome: Genetic and Clinical Profile.

Concolino P et al.

Molecular Diagnosis & Therapy, 2022

Cardiometabolic Health in Adolescents and Young Adults with Congenital Adrenal Hyperplasia.

Navardauskaite R et al.

Medicina (kaunas, Lithuania), 2022

Hyperinsulinemic-Euglycemic Clamp Strengthens the Insulin Resistance in Nonclassical Congenital Adrenal Hyperplasia.

Delai A et al.

The Journal of Clinical Endocrinology and Metabolism, 2022

Genotypic spectrum of 21-hydroxylase deficiency in an endogamous population.

Mahmoud RAA et al.

Journal of Endocrinological Investigation, 2022

Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond.

Troger T et al.

The Journal of Clinical Endocrinology and Metabolism, 2022

Increased Prevalence of Fractures in Congenital Adrenal Hyperplasia: A Swedish Population-based National Cohort Study.

Falhammar H et al.

The Journal of Clinical Endocrinology and Metabolism, 2022

Congenital Adrenal Hyperplasia-Current Insights in Pathophysiology, Diagnostics, and Management.

Claahsen-van der Grinten HL et al.

Endocrine Reviews, 2022

Low Adrenomedullary Function Predicts Acute Illness in Infants With Classical Congenital Adrenal Hyperplasia.

Weber J et al.

The Journal of Clinical Endocrinology and Metabolism, 2022

Copy Number Variations in Genetic Diagnosis of Congenital Adrenal Hyperplasia Children.

Tolba A et al.

Frontiers in Genetics, 2022

Allele-specific and multiplex PCR based tools for cost-effective and comprehensive genetic testing in Congenital Adrenal Hyperplasia.

Ravichandran L et al.

Methodsx, 2022

1–50 of 502 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."